Homebuilder M.D.C. being bought by Japan's Sekisui in a $4.9 billion deal
By Tomi Kilgore
M.D.C. stock shoots up to a 19-year high, as the deal values the shares at 19% premium
Shares of M.D.C. Holdings Inc. rocketed toward a 19-year high Thursday, after the Colorado-based homebuilder announced an agreement to be bought by Japan-based Sekisui House Ltd. in a deal valued at $4.9 billion.
The deal creates the fifth largest homebuilder in the U.S., based on the number of homes closed in 2022.
"MDC will help Sekisui House meet growing U.S. housing needs with enhanced capacity to deliver single-family houses and support customers' increasingly diversified demands - from breaking ground to choosing the specification and finishes in their new homes," the companies said in a statement.
Under the terms of the deal, M.D.C. shareholders will receive $63 in cash for each M.D.C. share they own. That represents an 18.7% premium to Wednesday's closing price of $53.09.
The stock (MDC) shot up 17.4% in premarket trading, putting it on track to open at the highest closing price seen since August 2005. The U.S.-listed shares (SKHSY) (JP:1928) of Sekisui were not yet active in the premarket.
"By leveraging Sekisui House technologies and cutting-edge building practices cultivated in Japan, MDC expects to deliver higher quality houses that enhance its position in the key states in which it operates," the companies said.
The deal is expected to close in the first half of 2024.
"As part of Sekisui House's U.S. family of brands, we expect new opportunities for growth across our footprint for our team members and within our customer offering," said M.D.C. Chief Executive David Mandarich.
M.D.C.'s stock has run up 39.1% over the past three months through Wednesday, while the iShares U.S. Home Construction ETF ITB has rallied 34.7% and the S&P 500 index SPX has gained 9.8%.
Sekisui's U.S. shares have advanced 19.1% over the past three months.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-18-24 0716ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom